ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 893,38
0,11%
DAX
18 430,05
1,42%
Brent Oil
83,095
-0,46%
Bitcoin
63 093,33
-0,11%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Celsion Corporation (CLSN)

  7. Celsion Corporation (CLSN) Actualités

CLSN

Celsion (CLSN)

Celsion Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CLSN
DateHeureSourceTitreSymboleSociété
15/06/202322h44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLSNCelsion Corporation
11/05/202315h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLSNCelsion Corporation
28/04/202322h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CLSNCelsion Corporation
28/04/202322h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CLSNCelsion Corporation
30/03/202314h22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLSNCelsion Corporation
21/03/202321h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLSNCelsion Corporation
03/10/202223h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLSNCelsion Corporation
19/09/202222h30GlobeNewswire Inc.Celsion Corporation Announces Company Name Change to Imunon, Inc.NASDAQ:CLSNCelsion Corporation
15/09/202217h55TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
15/09/202214h30GlobeNewswire Inc.Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian CancerNASDAQ:CLSNCelsion Corporation
13/09/202200h30GlobeNewswire Inc.Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13NASDAQ:CLSNCelsion Corporation
07/09/202215h15GlobeNewswire Inc.Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CLSNCelsion Corporation
01/09/202218h15TipRanksH.C. Wainwright Keeps Their Buy Rating on Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
01/09/202214h30GlobeNewswire Inc.Celsion Corporation Highlights Progress in its DNA-based Vaccine ProgramNASDAQ:CLSNCelsion Corporation
16/08/202200h00Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLSNCelsion Corporation
08/08/202214h30GlobeNewswire Inc.Celsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022NASDAQ:CLSNCelsion Corporation
19/07/202214h35GlobeNewswire Inc.Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)NASDAQ:CLSNCelsion Corporation
19/07/202214h30GlobeNewswire Inc.Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive OfficerNASDAQ:CLSNCelsion Corporation
26/06/202214h25TipRanksDawson James Sticks to Their Hold Rating for Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
24/06/202214h35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:CLSNCelsion Corporation
21/06/202214h30GlobeNewswire Inc.Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian CancerNASDAQ:CLSNCelsion Corporation
17/05/202212h15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Altimmune (ALT) and Albireo Pharma (ALBO)NASDAQ:CLSNCelsion Corporation
10/05/202214h30GlobeNewswire Inc.Celsion Corporation Highlights Pipeline Progress in Its Lead Development CandidatesNASDAQ:CLSNCelsion Corporation
09/05/202214h30GlobeNewswire Inc.Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022NASDAQ:CLSNCelsion Corporation
21/04/202217h30GlobeNewswire Inc.Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine CongressNASDAQ:CLSNCelsion Corporation
14/04/202214h30GlobeNewswire Inc.Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual MeetingNASDAQ:CLSNCelsion Corporation
13/04/202212h15TipRanksAnalysts’ Top Healthcare Picks: Celsion (CLSN), Acer Therapeutics (ACER)NASDAQ:CLSNCelsion Corporation
12/04/202214h30GlobeNewswire Inc.Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine CongressNASDAQ:CLSNCelsion Corporation
08/04/202222h30GlobeNewswire Inc.Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:CLSNCelsion Corporation
08/04/202212h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CLSNCelsion Corporation
 Showing the most relevant articles for your search:NASDAQ:CLSN

Dernières Valeurs Consultées

EU
CAP
Capgemini
NYSE
MCD
McDonalds
EU
PX1
CAC 40
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
EU
VIV
Vivendi
NYSE
MRK
Merck
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
EU
BEL20
Bel 20
EU
LR
Legrand
EU
EN
Bouygues
EU
HO
Thales
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés